litlas
Log inCreate account

Norman Wolmark

Active 1975–2026

Also published as
NORMAN WOLMARK
255
Papers
114,466
Citations
141
h-index
248
i10-index

Citations

Citations per year for Norman Wolmark1974: 3 citations1975: 3 citations1976: 7 citations1977: 12 citations1978: 11 citations1979: 12 citations1980: 3 citations1981: 5 citations1982: 10 citations1983: 19 citations1984: 9 citations1985: 34 citations1986: 41 citations1987: 37 citations1988: 40 citations1989: 86 citations1990: 66 citations1991: 101 citations1992: 102 citations1993: 84 citations1994: 123 citations1995: 109 citations1996: 116 citations1997: 132 citations1998: 212 citations1999: 320 citations2000: 365 citations2001: 541 citations2002: 436 citations2003: 533 citations2004: 558 citations2005: 712 citations2006: 688 citations2007: 774 citations2008: 780 citations2009: 801 citations2010: 880 citations2011: 819 citations2012: 731 citations2013: 798 citations2014: 683 citations2015: 750 citations2016: 624 citations2017: 585 citations2018: 542 citations2019: 2,083 citations2020: 2,218 citations2021: 2,003 citations2022: 1,709 citations2023: 1,253 citations2024: 2,035 citations2025: 899 citations2026: 33 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 8,228 citing papers, 30.6% of this breakdownChina: 1,911 citing papers, 7.1% of this breakdownUnited Kingdom: 1,834 citing papers, 6.8% of this breakdownItaly: 1,576 citing papers, 5.9% of this breakdownGermany: 1,193 citing papers, 4.4% of this breakdownCanada: 1,191 citing papers, 4.4% of this breakdownFrance: 1,057 citing papers, 3.9% of this breakdownNetherlands: 851 citing papers, 3.2% of this breakdownSpain: 749 citing papers, 2.8% of this breakdownSwitzerland: 679 citing papers, 2.5% of this breakdownAustralia: 663 citing papers, 2.5% of this breakdownJapan: 643 citing papers, 2.4% of this breakdown
0%30.6%Other 23.5%

Institutions

Fields

  • Medicine50.3%
  • Biochemistry, Genetics and Molecular Biology43%
  • Computer Science1.5%
  • Immunology and Microbiology1.1%
  • Engineering0.8%
  • Materials Science0.6%
  • Other2.7%

Topics

  • Breast Cancer Treatment Studies13.5%
  • Breast Lesions and Carcinomas5.4%
  • HER2/EGFR in Cancer Research5.4%
  • Breast Implant and Reconstruction3.3%
  • Colorectal Cancer Surgical Treatments2.5%
  • Estrogen and related hormone effects2.5%
  • Other67.4%

Coauthors

All papers

Open in search
  1. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

    Authors: Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P. Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa, Sandra M. Swain, Tatiana M. Prowell, Sibylle Loibl, D. Lawrence Wickerham, Jan Bogaerts, José Baselga, Charles M. Perou, Gideon M. Blumenthal, Jens‐Uwe Blohmer, Eleftherios P. Mamounas, Jonas Bergh, Semiglazov Vf, Robert Justice, Holger Eidtmann, Soonmyung Paik, Martine Piccart, Rajeshwari Sridhara, Peter A. Fasching, Leen Slaets, Shenghui Tang, Bernd Gerber, Charles E. Geyer, Richard Pazdur, Nina Ditsch, Priya Rastogi, W. Eiermann, Gϋnter von Minckwitz - The Lancet 2014 cited by 4,710

  2. Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

    Authors: Gϋnter von Minckwitz, Chiun‐Sheng Huang, Max S. Mano, Sibylle Loibl, Eleftherios P. Mamounas, Michael Untch, Norman Wolmark, Priya Rastogi, Andreas Schneeweiß, Andrés Redondo, Hans Holger Fischer, William Jacot, Alison Conlin, Claudia Arce-Salinas, Irene Wapnir, Christian Jackisch, Michael P. DiGiovanna, Peter A. Fasching, John Crown, P Wülfing, Zhimin Shao, Elena Rota Caremoli, Haiyan Wu, Lisa H. Lam, David Tesarowski, Melanie C. Smitt, Hannah Douthwaite, Stina Mui Singel, Charles E. Geyer - New England Journal of Medicine 2018 cited by 2,618

  3. Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

    Authors: Andrew Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D. Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmaña, Susan M. Domchek, Karen A. Gelmon, Simon J. Hollingsworth, Larissa A. Korde, Barbro Linderholm, Hanna Bandos, Elżbieta Senkus, Jennifer M. Suga, Zhimin Shao, Andrew W. Pippas, Zbigniew Nowecki, Tomasz Huzarski, Patricia A. Ganz, Peter C. Lucas, Nigel Baker, Sibylle Loibl, Robin McConnell, Martine Piccart, Rita K. Schmutzler, Guenther G. Steger, Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer - New England Journal of Medicine 2021 cited by 1,665

  4. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

    Authors: Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L. Baehner, Michael G. Walker, Drew Watson, Taesung Park, W. Douglas B. Hiller, Edwin R. Fisher, D. Lawrence Wickerham, John Bryant, Norman Wolmark - New England Journal of Medicine 2004 cited by 6,358

  5. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

    Authors: Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann Brown, Shaker R. Dakhil, Eleftherios P. Mamounas, Wilma L. Lingle, Pamela Klein, James N. Ingle, Norman Wolmark - New England Journal of Medicine 2005 cited by 5,353

  6. Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer

    Authors: Bernard Fisher, Stewart Anderson, John Bryant, Richard G. Margolese, Melvin Deutsch, Edwin R. Fisher, Jong‐Hyeon Jeong, Norman Wolmark - New England Journal of Medicine 2002 cited by 6,228

  7. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial

    Authors: Sibylle Loibl, Joyce O’Shaughnessy, Michael Untch, William M. Sikov, Hope S. Rugo, Mark D. McKee, Jens Huober, Mehra Golshan, Gϋnter von Minckwitz, David Maag, Danielle Sullivan, Norman Wolmark, Kristi McIntyre, José Ponce, Otto Metzger, Priya Rastogi, W. Fraser Symmans, Xuan Liu, Charles E. Geyer - The Lancet Oncology 2018 cited by 771

  8. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

    Authors: David N. Krag, Stewart Anderson, Thomas B. Julian, Ann Brown, Seth P. Harlow, Joseph P. Costantino, Takamaru Ashikaga, Donald L. Weaver, Eleftherios P. Mamounas, Lynne M Jalovec, Thomas G. Frazier, R. Dirk Noyes, André Robidoux, Hugh MC Scarth, Norman Wolmark - The Lancet Oncology 2010 cited by 1,919

  9. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

    Authors: Rosie Bradley, Jeremy Braybrooke, Richard Gray, Robert K Hills, Zulian Liu, Hongchao Pan, Richard Peto, David Dodwell, Paul McGale, Carolyn Taylor, Prudence A Francis, Michael Gnant, Francesco Perrone, Meredith M Regan, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Fran Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Raimund Jakesz, Christian Fesl, Olivia Pagani, Richard Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy Albain, Stewart Anderson, Rodrigo Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith Bliss, Etienne Brain, Lisa Carey, Robert Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain - The Lancet Oncology 2022 cited by 299

  10. NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2+

    Authors: Louis Fehrenbacher, Reena S. Cecchini, Charles E. Geyer, Priya Rastogi, Joseph P. Costantino, James N. Atkins, John Crown, Jonathan Polikoff, Jean-François Boileau, Louise Provencher, Christopher Stokoe, Timothy D. Moore, André Robidoux, Patrick J. Flynn, Virginia F. Borges, Kathy S. Albain, Sandra M. Swain, Soonmyung Paik, Eleftherios P. Mamounas, Norman Wolmark - Journal of Clinical Oncology 2019 cited by 420

  11. Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)

    Authors: Michael Gnant, Amylou C. Dueck, Sophie Frantal, Miguel Martín, H.J. Burstein, Richard Greil, Peter Fox, Antonio C. Wolff, Arlene Chan, Eric P. Winer, Georg Pfeiler, Kathy D. Miller, Marco Colleoni, Jennifer M. Suga, Gabor Rubovsky, Judith M. Bliss, Ingrid A. Mayer, Christian F. Singer, Zbigniew Nowecki, Olwen Hahn, Jacqui Thomson, Norman Wolmark, Kepa Amillano, Hope S. Rugo, Guenther G. Steger, Blanca Hernando Fernández de Aranguiz, Tufia C. Haddad, Antonia Perelló, Meritxell Bellet, Hannes Fohler, Otto Metzger, Anita Jallitsch-Halper, Kadine Solomon, Céline Schurmans, K. P. Theall, Dongrui R. Lu, Kathleen Tenner, Christian Fesl, Angela DeMichele, Erica L. Mayer, on behalf of the PALLAS groups and investigators - Journal of Clinical Oncology 2021 cited by 231

  12. openalex_id:w4226348827

    Authors: Rosie Bradley, Jeremy Braybrooke, Richard Gray, Robert K. Hills, Zulian Liu, Hongchao Pan, Richárd Pető, David Dodwell, Paul McGale, Carolyn Taylor, Prudence A. Francis, Michael Gnant, Francesco Perrone, Meredith M. Regan, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, R. Jakesz, Christian Fesl, Olivia Pagani, Richard D. Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy S. Albain, Stewart Anderson, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain cited by 223

  13. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

    Authors: Rosie Bradley, Jeremy Braybrooke, Richard J. Gray, Robert K. Hills, Zulian Liu, Richárd Pető, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn Taylor, Stewart Anderson, Richard D. Gelber, Luca Gianni, William Jacot, Heikki Joensuu, Alvaro Moreno‐Aspitia, Martine Piccart, Michael F. Press, Edward H. Romond, Dennis J. Slamon, Vera J. Suman, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Yaochen Wang, John Crown, Evandro de Azambuja, Suzette Delaloge, Helena Fung, Charles E. Geyer, M. Spielmann, Pinuccia Valagussa, Kathy S. Albain, Stewart Anderson, R. Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, Michael Gnant, Matthew Bidwell Goetz, Pam Goodwin, Pat Halpin-Murphy, Daniel Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori J. Pierce, Philip Poortmans, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Tanja Španić, Joseph A. Sparano, Guenther G. Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Timothy J. Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Kathleen I. Pritchard and 1 more - The Lancet Oncology 2021 cited by 348

  14. Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

    Authors: Priya Rastogi, Stewart Anderson, Harry D. Bear, Charles E. Geyer, Morton S. Kahlenberg, André Robidoux, Richard G. Margolese, James L. Hoehn, Victor G. Vogel, Shaker R. Dakhil, Deimante Tamkus, Karen King, Eduardo R. Pajon, Mary Wright, Jean Robert, Soonmyung Paik, Eleftherios P. Mamounas, Norman Wolmark - Journal of Clinical Oncology 2008 cited by 1,803

  15. Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial

    Authors: Charles E. Geyer, William M. Sikov, Jens Huober, Hope S. Rugo, Norman Wolmark, J. O’Shaughnessy, David Maag, Michael Untch, Mehra Golshan, José Ponce, Otto Metzger, Martin Dunbar, W. Fraser Symmans, Priya Rastogi, Joohyuk Sohn, Robyn R. Young, Gail S. Wright, C. Harkness, Kristi McIntyre, Denise A. Yardley, Sibylle Loibl - Annals of Oncology 2022 cited by 219

  16. Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

    Authors: Osama E. Rahma, Greg Yothers, Theodore S. Hong, Marcia M. Russell, Y. Nancy You, William A. Parker, Samuel A. Jacobs, Linda H. Colangelo, Peter C. Lucas, Marc J. Gollub, William A. Hall, Lisa A. Kachnic, Namrata Vijayvergia, Mark Allen O’Rourke, Bryan A. Faller, Richard K. Valicenti, Tracey E. Schefter, Sagila George, Radhika Kainthla, Philip J. Stella, Elin R. Sigurdson, Norman Wolmark, Thomas J. George - JAMA Oncology 2021 cited by 188

  17. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

    Authors: Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L. Baehner, Drew Watson, John Bryant, Joseph P. Costantino, Charles E. Geyer, D. Lawrence Wickerham, Norman Wolmark - Journal of Clinical Oncology 2006 cited by 2,577

  18. Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials

    Authors: Romain Cohen, Julien Taı̈eb, Jack Fiskum, Greg Yothers, Richard M. Goldberg, Takayuki Yoshino, Steven R. Alberts, Carmen J. Allegra, Aimery de Gramont, J. F. Seitz, Michael J. O’Connell, Daniel G. Haller, Norman Wolmark, Charles Erlichman, Alberto Zaniboni, Sara Lonardi, Rachel Kerr, Axel Grothey, Frank A. Sinicrope, Thierry André, Qian Shi - Journal of Clinical Oncology 2020 cited by 172

  19. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

    Authors: Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, Carol Redmond, Maureen Kavanah, Walter M. Cronin, Victor G. Vogel, André Robidoux, Nikolay Dimitrov, James N. Atkins, Mary B. Daly, Samuel Wieand, Elizabeth Tan-Chiu, Leslie G. Ford, Norman Wolmark, other National Surgical Adjuvant Breast, Bowel Project Investigators - JNCI Journal of the National Cancer Institute 1998 cited by 5,508

  20. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial

    Authors: David N. Krag, Stewart Anderson, Thomas B. Julian, Ann Brown, Seth P. Harlow, Takamaru Ashikaga, Donald L. Weaver, Bárbara Miller, Lynne M Jalovec, Thomas G. Frazier, R. Dirk Noyes, André Robidoux, Hugh MC Scarth, Denise Mammolito, David R. McCready, Eleftherios P. Mamounas, Joseph P. Costantino, Norman Wolmark - The Lancet Oncology 2007 cited by 1,078

  21. Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

    Authors: Edith A. Perez, Edward H. Romond, Vera J. Suman, Jong‐Hyeon Jeong, George W. Sledge, Charles E. Geyer, Silvana Martino, Priya Rastogi, Julie R. Gralow, Sandra M. Swain, Eric P. Winer, Gerardo Colón‐Otero, Nancy E. Davidson, E. Mamounas, Jo Anne Zujewski, Norman Wolmark - Journal of Clinical Oncology 2014 cited by 998

  22. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

    Authors: Frank A. Vicini, Reena S. Cecchini, Julia White, Douglas W. Arthur, Thomas B. Julian, Rachel Rabinovitch, Robert R. Kuske, Patricia A. Ganz, David S. Parda, Michael F. Scheier, Kathryn Winter, Soonmyung Paik, Henry M. Kuerer, Laura A. Vallow, Lori J. Pierce, Eleftherios P. Mamounas, Beryl McCormick, Joseph P. Costantino, Harry D. Bear, Isabelle Germain, G.S. Gustafson, Linda Grossheim, Ivy A. Petersen, Richard Hudes, Walter J. Curran, John Bryant, Norman Wolmark - The Lancet 2019 cited by 475

  23. Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation

    Authors: Bernard Fisher, Jong‐Hyeon Jeong, Stewart Anderson, John Bryant, Edwin R. Fisher, Norman Wolmark - New England Journal of Medicine 2002 cited by 1,386

  24. Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial

    Authors: Stephen Johnston, Shannon Puhalla, Duncan Wheatley, Alistair Ring, Peter Barry, Chris Holcombe, Jean Francois Boileau, Louise Provencher, André Robidoux, Mothaffar F. Rimawi, Stuart McIntosh, I. Shalaby, Robert C. Stein, Michael P. Thirlwell, David Dolling, James P. Morden, Claire Snowdon, Sophie Perry, Chester Cornman, Leona Batten, Lisa K. Jeffs, Andrew Dodson, Vera Martins, Arjun Modi, C. Kent Osborne, Katherine L. Pogue–Geile, Maggie C.U. Cheang, Norman Wolmark, Thomas B. Julian, Kate Fisher, Mairead MacKenzie, Maggie Wilcox, Cynthia Huang Bartlett, María Koehler, Mitch Dowsett, Judith M. Bliss, Samuel A. Jacobs - Journal of Clinical Oncology 2018 cited by 235